Hi Nuts et al,
Looking back, Provenge and Yerevoy were approved for sale by the FDA and subsequently got their health fund subsidies on the basis of Median PFS benefit around 4 months, from their Phase 3 trials.
On that basis, I'm hoping we see a similar result for Cvac in the Phase 2b trial result. That should please the market and anything better would be just gravy.
One way or another, only about 4 weeks till the result is released.
Conjecture that the results have been leaked to some are just hogwash IMO. There's an independant authority that collects the patient data from the various collection centres and carries out the analysis prior to sending it to PRR. I doubt very much if that has been completed yet.
- Forums
- ASX - By Stock
- IMM
- to ymav4294: ct scan frequency and pfs results
to ymav4294: ct scan frequency and pfs results, page-13
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
30.0¢ |
Change
-0.005(1.64%) |
Mkt cap ! $436.3M |
Open | High | Low | Value | Volume |
30.5¢ | 31.3¢ | 30.0¢ | $960.6K | 3.161M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 188729 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 46153 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 76315 | 0.300 |
11 | 188158 | 0.295 |
13 | 374153 | 0.290 |
7 | 1039385 | 0.285 |
9 | 253967 | 0.280 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 4426 | 1 |
0.315 | 57600 | 2 |
0.320 | 165083 | 4 |
0.325 | 239547 | 4 |
0.330 | 68045 | 5 |
Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |